Impact of Hormone Receptor Status on Development of Brain Metastases from HER2+Breast Cancer

被引：0
|
作者：
Sachar, S. [1 ]
Chen, E. [2 ]
Harris, E. E. [2 ]
Montero, A. J. [3 ]
Choi, S. [4 ]
机构：
[1] Touro Coll Osteopath Med, New York, NY USA
[2] Univ Hosp Seidman Canc Ctr, Dept Radiat Oncol, Cleveland, OH USA
[3] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2138
引用
收藏
页码：E62 / E63
页数：2
相关论文
共 50 条
  • [21] Intrathecal AAV9. trastuzumab for Prophylaxis and Treatment of HER2+Breast Cancer Brain Metastases
    Rothwell, William T.
    Bell, Peter
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 129 - 129
  • [22] Comparison of outcomes of hormone receptor (HR) negative, and HER2 negative (triple negative, TN) to HER2+breast cancer (BC) patients (pts): impact of HER2 status.
    Man, MC
    Moore, D
    Chen, YY
    Rugo, HS
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S142 - S143
  • [23] Co-expression of hormone receptors in HER2+breast cancer
    Chen, Z. W.
    Hanna, W. M.
    Zubovits, J.
    Saad, R. S.
    Kahn, H.
    Nofech-Mozes, S.
    HISTOPATHOLOGY, 2010, 57 : 36 - 37
  • [24] IMPACT OF HORMONE RECEPTOR STATUS AND HER2 ON SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS
    Xiao, H.
    Tan, F.
    Huang, Y.
    Feldman, J.
    Koniaris, L.
    Gummadi, S.
    Adunlin, G. B.
    Ali, A. A.
    VALUE IN HEALTH, 2013, 16 (03) : A131 - A131
  • [25] A positive conversion in hormone receptor and HER2 status might have an impact on survival after liver resection for breast cancer metastases
    Altundag, Kadri
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (04) : 907 - 907
  • [26] A positive conversion in hormone receptor and HER2 status might have an impact on survival after liver resection for breast cancer metastases
    Kadri Altundag
    Irish Journal of Medical Science (1971 -), 2018, 187 : 907 - 907
  • [27] Estrogen receptor status: a prognostic predictor of outcome in HER-2 positive breast cancer with brain metastases
    Vallow, L.
    Hines, S.
    Jain, A.
    Tan, W.
    Buskirk, S.
    Perez, E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S171 - S172
  • [28] Impact of HER2 status in breast cancer patients receiving stereotactic radiosurgery for brain metastases.
    O'Meara, WP
    Seidman, AD
    Yamada, Y
    McCormick, B
    Diamond, S
    Gutin, PH
    Narayana, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 37S - 37S
  • [29] Genomics of HER2+breast cancer
    Perou, C.
    CANCER RESEARCH, 2022, 82 (04)
  • [30] Impact of extracranial disease status on survival after initial central nervous system (CNS) involvement and radiation therapy in HER2+breast cancer brain metastases (BCBM).
    Noteware, Laura
    Ramirez, Luis
    Dalal, Nicole
    Herndon, James Emmett
    Floyd, Scott R.
    Van Swearingen, Amanda E. D.
    Anders, Carey K.
    Sammons, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345